INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
4.805
+0.245 (5.37%)
Nov 21, 2024, 2:26 PM EST - Market open
INmune Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 107 | 203 | 114 | 182 | 232 | 62 | |
| Market Cap Growth | -2.38% | 78.35% | -37.49% | -21.41% | 270.69% | - | |
| Enterprise Value | 70 | 175 | 72 | 112 | 207 | 55 | |
| Last Close Price | 4.56 | 11.26 | 6.34 | 10.20 | 17.22 | 5.80 | |
| PS Ratio | 2835.75 | 1309.19 | 304.22 | 1005.53 | 21052.15 | - | |
| PB Ratio | 2.61 | 5.32 | 1.89 | 2.27 | 5.98 | 2.65 | |
| P/TBV Ratio | 5.37 | 9.74 | 2.61 | 2.86 | 10.41 | 8.80 | |
| EV/Sales Ratio | 1677.79 | 1127.89 | 191.85 | 619.14 | 18856.25 | - | |
| Debt / Equity Ratio | 0.08 | 0.27 | 0.25 | 0.19 | 0.00 | 0.01 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
| Quick Ratio | 2.53 | 2.07 | 5.55 | 18.42 | 13.38 | 10.91 | |
| Current Ratio | 2.59 | 2.16 | 5.92 | 18.95 | 13.51 | 11.09 | |
| Return on Equity (ROE) | -98.97% | -61.09% | -38.91% | -51.00% | -38.80% | -38.25% | |
| Return on Assets (ROA) | -44.97% | -26.78% | -17.85% | -25.92% | -23.47% | -27.78% | |
| Return on Capital (ROIC) | -52.34% | -29.98% | -18.98% | -27.12% | -24.38% | -28.83% | |
| Earnings Yield | -39.35% | -14.79% | -23.99% | -16.67% | -5.22% | -12.29% | |
| FCF Yield | -24.55% | -5.90% | -19.94% | -15.66% | -3.86% | -8.62% | |
| Buyback Yield / Dilution | -5.16% | -0.30% | -11.14% | -34.55% | -16.70% | -18.39% | |
| Total Shareholder Return | -5.16% | -0.30% | -11.14% | -34.55% | -16.70% | -18.39% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.